nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Keratitis—Isotretinoin—peripheral nervous system neoplasm	0.0144	0.0144	CcSEcCtD
Latanoprost—Dermatitis atopic—Tretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Latanoprost—Dermatitis atopic—Isotretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Latanoprost—Dermatitis atopic—Melphalan—peripheral nervous system neoplasm	0.0125	0.0125	CcSEcCtD
Latanoprost—Stinging—Tretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Latanoprost—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Latanoprost—Blepharitis—Alitretinoin—peripheral nervous system neoplasm	0.0115	0.0115	CcSEcCtD
Latanoprost—Embolism—Alitretinoin—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Latanoprost—Eye irritation—Tretinoin—peripheral nervous system neoplasm	0.011	0.011	CcSEcCtD
Latanoprost—Eye irritation—Isotretinoin—peripheral nervous system neoplasm	0.011	0.011	CcSEcCtD
Latanoprost—Keratitis—Alitretinoin—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Latanoprost—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.0102	0.0102	CcSEcCtD
Latanoprost—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.0102	0.0102	CcSEcCtD
Latanoprost—Inflammation—Isotretinoin—peripheral nervous system neoplasm	0.00966	0.00966	CcSEcCtD
Latanoprost—Inflammation—Tretinoin—peripheral nervous system neoplasm	0.00966	0.00966	CcSEcCtD
Latanoprost—Dermatitis atopic—Alitretinoin—peripheral nervous system neoplasm	0.0096	0.0096	CcSEcCtD
Latanoprost—Photophobia—Tretinoin—peripheral nervous system neoplasm	0.0088	0.0088	CcSEcCtD
Latanoprost—Photophobia—Isotretinoin—peripheral nervous system neoplasm	0.0088	0.0088	CcSEcCtD
Latanoprost—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.00877	0.00877	CcSEcCtD
Latanoprost—Dry eye—Isotretinoin—peripheral nervous system neoplasm	0.00866	0.00866	CcSEcCtD
Latanoprost—Dry eye—Tretinoin—peripheral nervous system neoplasm	0.00866	0.00866	CcSEcCtD
Latanoprost—Eye irritation—Alitretinoin—peripheral nervous system neoplasm	0.00832	0.00832	CcSEcCtD
Latanoprost—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.00771	0.00771	CcSEcCtD
Latanoprost—Eczema—Tretinoin—peripheral nervous system neoplasm	0.00757	0.00757	CcSEcCtD
Latanoprost—Eczema—Isotretinoin—peripheral nervous system neoplasm	0.00757	0.00757	CcSEcCtD
Latanoprost—Inflammation—Alitretinoin—peripheral nervous system neoplasm	0.00732	0.00732	CcSEcCtD
Latanoprost—Photophobia—Alitretinoin—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Latanoprost—Dry eye—Alitretinoin—peripheral nervous system neoplasm	0.00656	0.00656	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Tretinoin—peripheral nervous system neoplasm	0.00613	0.00613	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Isotretinoin—peripheral nervous system neoplasm	0.00613	0.00613	CcSEcCtD
Latanoprost—Asthma—Tretinoin—peripheral nervous system neoplasm	0.00588	0.00588	CcSEcCtD
Latanoprost—Asthma—Isotretinoin—peripheral nervous system neoplasm	0.00588	0.00588	CcSEcCtD
Latanoprost—Eczema—Alitretinoin—peripheral nervous system neoplasm	0.00574	0.00574	CcSEcCtD
Latanoprost—Inflammation—Etoposide—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Tretinoin—peripheral nervous system neoplasm	0.00546	0.00546	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Isotretinoin—peripheral nervous system neoplasm	0.00546	0.00546	CcSEcCtD
Latanoprost—Urinary tract infection—Isotretinoin—peripheral nervous system neoplasm	0.0051	0.0051	CcSEcCtD
Latanoprost—Conjunctivitis—Tretinoin—peripheral nervous system neoplasm	0.0051	0.0051	CcSEcCtD
Latanoprost—Conjunctivitis—Isotretinoin—peripheral nervous system neoplasm	0.0051	0.0051	CcSEcCtD
Latanoprost—Urinary tract infection—Tretinoin—peripheral nervous system neoplasm	0.0051	0.0051	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Dactinomycin—peripheral nervous system neoplasm	0.00501	0.00501	CcSEcCtD
Latanoprost—Embolism—Epirubicin—peripheral nervous system neoplasm	0.00484	0.00484	CcSEcCtD
Latanoprost—Keratitis—Epirubicin—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Alitretinoin—peripheral nervous system neoplasm	0.00464	0.00464	CcSEcCtD
Latanoprost—Connective tissue disorder—Melphalan—peripheral nervous system neoplasm	0.00456	0.00456	CcSEcCtD
Latanoprost—Embolism—Doxorubicin—peripheral nervous system neoplasm	0.00448	0.00448	CcSEcCtD
Latanoprost—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.00446	0.00446	CcSEcCtD
Latanoprost—Keratitis—Doxorubicin—peripheral nervous system neoplasm	0.00443	0.00443	CcSEcCtD
Latanoprost—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.00428	0.00428	CcSEcCtD
Latanoprost—Dermatitis atopic—Epirubicin—peripheral nervous system neoplasm	0.0042	0.0042	CcSEcCtD
Latanoprost—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.00419	0.00419	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00414	0.00414	CcSEcCtD
Latanoprost—Erythema—Tretinoin—peripheral nervous system neoplasm	0.0041	0.0041	CcSEcCtD
Latanoprost—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.0041	0.0041	CcSEcCtD
Latanoprost—Back pain—Topotecan—peripheral nervous system neoplasm	0.00399	0.00399	CcSEcCtD
Latanoprost—Back pain—Tretinoin—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Latanoprost—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Latanoprost—Dermatitis atopic—Doxorubicin—peripheral nervous system neoplasm	0.00388	0.00388	CcSEcCtD
Latanoprost—Urinary tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Latanoprost—Conjunctivitis—Alitretinoin—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Latanoprost—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Latanoprost—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Latanoprost—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00384	0.00384	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Latanoprost—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00355	0.00355	CcSEcCtD
Latanoprost—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Latanoprost—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Latanoprost—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Latanoprost—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Latanoprost—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Latanoprost—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Latanoprost—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00347	0.00347	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00346	0.00346	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00346	0.00346	CcSEcCtD
Latanoprost—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Latanoprost—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Latanoprost—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00344	0.00344	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Latanoprost—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Latanoprost—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Latanoprost—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00335	0.00335	CcSEcCtD
Latanoprost—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Latanoprost—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Latanoprost—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Latanoprost—Oedema—Melphalan—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Latanoprost—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Latanoprost—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Latanoprost—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Latanoprost—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Latanoprost—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Latanoprost—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Latanoprost—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Latanoprost—Inflammation—Epirubicin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Latanoprost—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Latanoprost—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Latanoprost—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.0031	0.0031	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Latanoprost—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Latanoprost—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Latanoprost—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Latanoprost—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Latanoprost—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Latanoprost—Inflammation—Doxorubicin—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Latanoprost—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Latanoprost—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Latanoprost—Back pain—Vincristine—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Latanoprost—Pain—Topotecan—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Latanoprost—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Latanoprost—Pain—Tretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Latanoprost—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Latanoprost—Pain—Melphalan—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Latanoprost—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Latanoprost—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Latanoprost—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Latanoprost—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Latanoprost—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Latanoprost—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Latanoprost—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Latanoprost—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Latanoprost—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Latanoprost—Eczema—Epirubicin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Latanoprost—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Latanoprost—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Latanoprost—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Latanoprost—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Latanoprost—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Latanoprost—Oedema—Vincristine—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Latanoprost—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Latanoprost—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Latanoprost—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Latanoprost—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Latanoprost—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Latanoprost—Back pain—Etoposide—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Latanoprost—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Latanoprost—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Latanoprost—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Latanoprost—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Latanoprost—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Latanoprost—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Latanoprost—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Latanoprost—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Latanoprost—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Latanoprost—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Latanoprost—Rash—Topotecan—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Latanoprost—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Latanoprost—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Latanoprost—Headache—Topotecan—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Latanoprost—Rash—Tretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Latanoprost—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Latanoprost—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Latanoprost—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Latanoprost—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Latanoprost—Headache—Tretinoin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Latanoprost—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Latanoprost—Pain—Vincristine—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Latanoprost—Rash—Melphalan—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Latanoprost—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Latanoprost—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Latanoprost—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Latanoprost—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Latanoprost—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Latanoprost—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Latanoprost—Pain—Cisplatin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Latanoprost—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Latanoprost—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Latanoprost—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Latanoprost—Pain—Etoposide—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Latanoprost—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Latanoprost—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Latanoprost—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Latanoprost—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Latanoprost—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Latanoprost—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Latanoprost—Rash—Vincristine—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Latanoprost—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Latanoprost—Headache—Vincristine—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Latanoprost—Pruritus—Etoposide—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Latanoprost—Rash—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Latanoprost—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Latanoprost—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Latanoprost—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Latanoprost—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Latanoprost—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Latanoprost—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Latanoprost—Rash—Etoposide—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Latanoprost—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Latanoprost—Headache—Etoposide—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Latanoprost—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Latanoprost—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Latanoprost—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Latanoprost—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Latanoprost—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Latanoprost—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000996	0.000996	CcSEcCtD
Latanoprost—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000988	0.000988	CcSEcCtD
Latanoprost—Pain—Epirubicin—peripheral nervous system neoplasm	0.000948	0.000948	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000935	0.000935	CcSEcCtD
Latanoprost—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Latanoprost—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000877	0.000877	CcSEcCtD
Latanoprost—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000784	0.000784	CcSEcCtD
Latanoprost—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000733	0.000733	CcSEcCtD
Latanoprost—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000726	0.000726	CcSEcCtD
Latanoprost—Rash—Epirubicin—peripheral nervous system neoplasm	0.000699	0.000699	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000698	0.000698	CcSEcCtD
Latanoprost—Headache—Epirubicin—peripheral nervous system neoplasm	0.000695	0.000695	CcSEcCtD
Latanoprost—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000678	0.000678	CcSEcCtD
Latanoprost—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000647	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000646	0.000646	CcSEcCtD
Latanoprost—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
